Comparison of aspirin alone versus aspirin plus ticlopidine after coronary artery stenting. 1996

C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
Cardiovascular Division, University of Alabama at Birmingham 35294, USA.

This prospective nonrandomized study was performed comparing aspirin alone (n = 46) versus aspirin and ticlopidine (p = 338) following native coronary artery stenting. There were significantly more stent thrombosis events in the aspirin-only group than in the aspirin and ticlopidine group (6.5% vs 0.9%, p = 0.02) and significantly more Q-wave myocardial infarctions and cardiac-related deaths in the aspirin-only group than in the aspirin and ticlopidine group (6.5% vs 0%, p = 0.002 and 4.4% vs 0.3% p = 0.02, respectively).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010975 Platelet Aggregation Inhibitors Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. Antiaggregants, Platelet,Antiplatelet Agent,Antiplatelet Agents,Antiplatelet Drug,Blood Platelet Aggregation Inhibitor,Blood Platelet Antagonist,Blood Platelet Antiaggregant,PAR-1 Antagonists,Platelet Aggregation Inhibitor,Platelet Antagonist,Platelet Antagonists,Platelet Antiaggregant,Platelet Antiaggregants,Platelet Inhibitor,Protease-Activated Receptor-1 Antagonists,Antiplatelet Drugs,Blood Platelet Aggregation Inhibitors,Blood Platelet Antagonists,Blood Platelet Antiaggregants,Platelet Inhibitors,Agent, Antiplatelet,Aggregation Inhibitor, Platelet,Antagonist, Blood Platelet,Antagonist, Platelet,Antiaggregant, Blood Platelet,Antiaggregant, Platelet,Drug, Antiplatelet,Inhibitor, Platelet,Inhibitor, Platelet Aggregation,PAR 1 Antagonists,Platelet Antagonist, Blood,Platelet Antiaggregant, Blood,Protease Activated Receptor 1 Antagonists
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
August 2011, Journal of the American College of Cardiology,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
September 2003, Internal medicine (Tokyo, Japan),
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
February 2001, The American journal of cardiology,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
June 2001, The Journal of invasive cardiology,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
December 2010, Circulation,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
February 2000, Circulation,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
March 2003, Journal of the American College of Cardiology,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
December 1996, Circulation,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
December 1999, The American journal of cardiology,
C M Goods, and K F al-Shaibi, and M W Liu, and J S Yadav, and A Mathur, and S P Jain, and L S Dean, and S S Iyer, and J M Parks, and G S Roubin
April 2004, American heart journal,
Copied contents to your clipboard!